¤K¤Q¤»¦~¤º¬ì±M¬ìÂå®v¦Ò¸Õµ§¸ÕÃD -- ®ø¤Æ¬ì

(A)
1. ¤U¦C¦³ÃöÆP©Ê¿M»Äà­úC(Alkaline phosphatase)¤§±Ô­z¡A¦óªÌ¬°»~¡C
A.¥i¥Ñ°©Àf¡B¨xŦ¡B­L½L¤Î³è²G¸¢¬¡¤Æ²£¥Í¡C
B.¦bµL°©¯f¤ÎÃh¥¥®É¨ä¼W°ª³q±`ªí¥Ü¨xŦÁx¹D¯e¯f¡C
C.¦b¨x¥~Áx¹Dªý¶ë®ÉÅãµÛ¼W°ª¡C
D.¦b¨xŦ¯e¯f®É5'-nucleotidase¦P®É¼W°ª¡C
E.®û¼í©Ê¨x¯f(Infiltrative liver disease)®É¥ç¼W°ª¡C
 
(E)
2. ¦³ÃöH2 Receptor Antagonist¡A¤U¦C¦óºØ±Ô­z¬°«D¡C
A.H2 Receptor¦s¦b©ó­G¾À²Ó­M¤Î¤l®c¡C
B.ªÅ¸¡¤ÎÀ\«á­G»Ä¤Àªc§¡¥i­°§C¡C
C.®ø¤Æ©Ê¼ìºÅ¤§Â¡¦X²v¦b6¦Ü8¶g«á¥i¹F¦Ê¤À¤§¤K¤Q¡C
D.¹ï¬Y¨ÇßÓª«¥i¯à²£¥Í¬Û¤¬§@¥Î(interaction)¡C
E.ªø´Á¨Ï¥Î¥i¯àµo¥ÍÃþÀù(carcinoid)¡C
 
(E)
3. ¤U¦C¯e¯f¥i¨Ï­G±ÆªÅ®É¶¡¥[³t¡A°£¤F
A.Pancreatic insufficiency
B.Celiac Sprue
C.Zolllinger-Ellison Syndrome
D.Duodenal ulcer
E.Reflux esophagitis
 
(B)
4. ¦b¦UºØ¯f¬r¨xª¢¤¤¡A¨ä¯f¬rÄÝDNA virusªÌ¬°
A.Hepatitis A
B.Hepatitis B
C.Hepatitis C
D.Hepatitis D
E.Hepatitis E
 
(C)
5. ¦³ÃöÁx©T¾JÁxµ²¥Û¤§§Î¦¨¶É¦V¡A¤U¦C¦óªÌ¬°»~¡H
A.ªÎ­D¯g
B.°j¸z¯e¯f©Î¤Á°£
C.¨xµw¤Æ¯g
D.¦h²£°ü¤k
E.ªA¥ÎßÓª«¦pClofibrate
 
(A)
6. ¦³Ãö«DÃþ©T¾J§Üª¢ßÓª«¹ï­GÖß½¤¤§¶Ë®`¾÷Âध±Ô­z¡A¦óªÌ¬°»~¡H
A.¨ë¿E­G¾À²Ó­M¾É­P­G»Ä¹L°ª
B.§í¨î«e¦C¸¢¯À¦X¦¨¡A´î¤Ö­GÖß²G¤Î¦¸ºÒ»Ä¤Àªc
C.­°§C­GÖß½¤¦å¬y¶q
D.´î¤Ö­GÖß½¤²Ó­M¦A¥Í
E.¹ï°ªÄÖ±wªÌ¼vÅT¸û¤j
 
(D)
7. ¦³ÃöDumping Syndrome¤§¶¼­¹ª`·N¨Æ¶µ¡A¤U¦C¤è¦¡¡A¦óªÌ¬°«D¡H
A.¦hÄá¨ú°ª³J¥Õ¡B°ª¯×ªÕ­¹ª«
B.ÁקK°ªºÒ¤ô¤Æ¦Xª«¡B°ª»Ä¡B°ª¿@«×ºÒ¤ô¤Æ¦Xª«­¹ª«
C.¤Ö¶q¦hÀ\
D.¶º«e¶º«á¦h³Ü¤ô¥÷
E.²ÓÄZºCÃ`
 
(D)
8. «æ©Ê¯ØŦª¢¥i¯à¤Þµo¤U¦CÁ{§É²{¶H¡A°£¤F
A.¥Õ¦å²y¼W¥[
B.¦å²M¾ý¯»»Ã¯À¼W°ª
C.¦å¿}¼W°ª
D.¦å¶t¼W°ª
E.¦¨¤H©I§lµ~­¢¯g(ARDS)
 
(C)
9. ¤U¦C¥i¤Þ°_¨x·l¶Ë¤§ßÓª«¤¤¡A¦óªÌ¨äÁ{§Éªí¼x¬°Áx¥Äº¢¯d(Cholestasis)¡C 1. Acetaminophen 2. Amiodarone 3. Chlorpromazine 4. Erythromycin 5. Halothane
A.1, 2
B.2, 3, 4
C.3, 4
D.4, 5
E.1, 5
 
(E)
10. ¤U¦C¿ò¶Ç©Ê­G¸z®§¦×¯g¤¤¦óªÌµo¥Í¸zÀù¶É¦V¸û¨u¨£¡H 1. Familial colonic polyposis 2. Gardner's Syndrome 3. Turcot's Syndrome 4. Peutz-Jeghers Syndrome 5. Juvenile polyposis
A.1, 2, 3
B.2, 3, 4
C.3, 4, 5
D.1, 4, 5
E.4, 5
 
(D)
11. ¤U¦C¦³Ãö¤j¸z¸~½F¤§±Ô­z¦óªÌ¬°«D
A.¤j¸zÀùµ´¤j¦h¼Æ¥Ñ¸¢½F®§¦×(adenomatous polyps)ÂàÅܦӨÓ
B.¬ù¤@¥bªº¤j¸z¸zÀù¯f¤H¨äÁT«K¼ç¦å¬°³±©Ê
C.¥k¤j¸zÀù¤HªºÁT«K¥~Æ[±`µL²§¼Ë¡A¦ý¯f¤H±`¦³¯ÊÅK©Ê³h¦å
D.CEA (carcinoembryonic antigen)Àˬd¹ï¦­´Á¿zÀˤj¸zÀù«Ü¦³¥Î
E.¤â«ü¨z¶E¡A¥iÀˬd¨ì¬ù¤@¥bªºª½¸zÀù
 
(E)
12. ¤U¦C¦³Ãö«Âº¸»¹¤ó¯f(Wilson's disease)ªº±Ô­z¦óªÌ¤£¥¿½T¡H
A.¥»¯f¬°Áô©Ê¿ò¶Ç(autosomal recessive)
B.¥»¯f¥i¯à¥H²rÃz©Ê¨xª¢ªí²{
C.¥»¯f²§±`ªº°ò¦]¤w³Q½T»{¦ì¦b²Ä¤Q¤T¹ï¬V¦âÅé¤W
D.¬ù5%ªº¯f¤H¦å²Mceruloplasmin¿@«×¤j©ó200 mg/L
E.Kayser-Fleischer ring ¬°¥»¯f©Ò¿W¨ãªº¯S¼x
 
(A)
13. ¤U¦C¦³Ãö¨x²Ó­MÀùªº±Ô­z¡A¦óªÌ¬°«D¡H
A.§íÀù°ò¦]P53¬ðÅÜ»P¶ÀÄT¬r¯À(aflatoxin)µLÃö
B.ºC©ÊC«¬¨xª¢¶§©ÊªÌ¡A¨x²Ó­MÀùªºµo¥Í¥­§¡¦~ÄÖ¬ù±ß¤Q¦~
C.¨x¬ï¨ëÀˬd¤Þ°_¸~½F²Ó­Mªu¥ÍÀ˸ô®|´²§Gªº¾÷·|¤p¡A¥²­n®É¥i¬I¦æ
D.£\-­L¨à³J¥Õ¿@«×¦b¤p©ó3¤½¤À¥H¤Uªº¨xÀù¯f¤H¤¤¡A¬ù1/3¯f¤H¬°¥¿±`
E.¨xŦ²¾´Ó¬°¥i¦æªºªvÀø¤èªk¤§¤@¡A¥i¦b¬Y¨Ç¯f¤H¬I¦æ
 
(D)
14. ¥H¤zÂZ¯ÀªvÀøºC©Ê¯f¬r©Ê¨xª¢¡A¤U¦C°Æ§@¥Î¦óªÌ¸û¥i¯à¤£¥i°f(irreversible)¡H
A.°©ÅèÀ£§í(marrow suppression)
B.±¡ºü¤£Ã­©w
C.¤ò¾v´î¤Ö(alopecia)
D.¦ÛÅé§K¬Ì©Ê¥Òª¬¸¢ª¢(autoimmune thyroiditis)
E.¿}§¿¯f
 
(D)
15. ÅܺØB«¬¨xª¢¯f¬r(HBV variants)ªº±Ô­z¡A¤U¦C¦óªÌ¤£¥¿½T¡H
A.B«¬¨xª¢´c¤Æªº¯f¤HÁöHBeAg³±©Ê¡A¦ý¦å¤¤HBV DNA¥i¶§©Ê
B.³Ì±`¨£ªºÅܺØB«¬¨xª¢¯f¬r¬°precore°Ï®Ö»Ä1896¦³G¡÷A¬ðÅÜ
C.¦P¤@­Ó¯f¤H³¥ºØ(wild type)»PÅܺØB«¬¨xª¢¯f¬r¥i¥H¦P®É¦s¦b
D.PrecoreÅܺØB«¬¨xª¢¯f¬r¸û·|¤Þ°_²rÃz©Ê¨xª¢
E.¯f¤HÁöanti-HBs¶§©Ê¡A¦ý¦b¨u¨£±¡ªp¤U¡A¤´·|¨üB«¬¨xª¢¯f¬r·P¬V¡A¤D¦]¦³S°ò¦]ÅܺØHBV¤§¬G
 
(A)
16. ¤U¦C¦³ÃöC«¬¨xª¢ªº±Ô­z¡A¦óªÌ¦³»~¡H
A.³Q±µÄ²¹LºC©ÊC«¬¨xª¢¯f¤HÅé²Gªº°wÀY¨ë¶Ë¡A¬ù50%¥H¤Wªº¤H·|±oºC©ÊC«¬¨xª¢
B.«æ©ÊC«¬¨xª¢¯f¬r·P¬V«á¡A¹ï¥H«áªº¦A·P¬V¨ÃµL§K¬Ì©Ê
C.C«¬¨xª¢¯f¬r¥D­n¤À§G¦b¨ü·P¬V¤§¨x²Ó­Mªº¨x²Ó­M½è¤W(cytoplasm)
D.C«¬¨xª¢¯f¬rªº°ò¦]«¬»P¦å¤¤¿@«×¬O¨M©w¤zÂZ¯ÀªvÀø¦³®Ä§_ªº­«­n¨M©w¦]¯À
E.©Ê¦æ¬°¤£¬OC«¬¨xª¢¯f¬r¶Ç¬Vªº¦³®Ä³~®|
 
(C)
17. ¦Ûµo©Ê²Óµß©Ê¸¡½¤ª¢(spontaneous bacterial peritonitis, SBP)¡A¤U¦C±Ô­z¦óªÌ¬°«D¡H
A.¦³¸¡¤ôªº¨xµw¤Æ¯f¤HÁ{§É¤W´c¤Æ¡AÀ³§@¸¡¤ôÀˬd¥H±Æ°£SBP
B.·í¸¡¤ô¤¤ªº¦h§Î®Ö¥Õ¦å²y¼Æ(PMN)¶W¹L250/ul¡ASBPªº¶EÂ_¦³¥i¯à
C.¦]SBP±`¬°­²Äõ¤ó³±©Êµß©Ò­P¡AaminoglycosidesÀ³°µ¬°²Ä¤@½u¥ÎßÓ¤§¤@
D.­Y§Ü¥Í¯ÀªvÀø«á¯f¤H±¡§ÎÄ~Äò´c¤Æ©Î²Óµß°ö¾i¬°³±©Ê¡A48-72¤p®É«áÀ³¦A°µ¸¡¤ôÀˬd
E.Norfloxacin¥i­°§CSBPªº´_µo²v
 
(A)
18. ¤U¦C¦³ÃöÁxÅnµ²¥Û¤ÎÁxÅnª¢ªº±Ô­z¦óªÌ¤£¥¿½T¡H
A.ÁxÅnµ²¥Ûªº¯kµh¬°¤@°}¤@°}ªºµ±µh¡A«D«ùÄò(steady)©Ê¯kµh
B.µL¯gª¬¤§ÁxÅnµ²¥Û¤£¥²«æµÛ¶}¤M
C.ÁöµM«æ©ÊÁxÅnª¢¬ù75%¥i¥ÎßÓª«±±¨î¡A¦ý·|´_µo¡A¬G¤Î¦­¶}¤M¬°¤Wµ¦
D.¦­´Á«æ©ÊÁxÅnª¢¤£¤@©w¦³²Óµß·P¬V¡A¦ý¤´©yÀR¯ßª`®g§Ü¥Í¯À
E.¬ù5¨ì10%ªº«æ©ÊÁxÅnª¢¯f¤H¦b¶}¤M®É§ä¤£¨ìªý¶ëcystic ductªºµ²¥Û
 
(D)
19. ¤U¦C¦óºØÀˬd¹ï°Ï§O§l¦¬¤£¨}(malabsorption)©Î®ø¤Æ¤£¨}(maldigestion)¸û¦³À°§U¡H 1. ©w¶qÁT«K¤¤¯×ªÕ¶q 2. Schilling test 3. secretin test 4. D-xylose absorption 5. ¤p¸zÖß½¤¥ÍÀˤÁ¤ù
A.1, 3, 4
B.2, 3, 4
C.2, 5
D.4, 5
E.2, 3, 5
 
(D)
20. ¤À§O³æ¿W¨Ï¥Î®É¡A¤U¦C¨º¤TºØßÓª«¹ï­G«Õªù±ìµß(Helicobacter pylori)¸û¦³®Ä¡H(ÁöµM¦bÁ{§ÉÀ³¥Î®É¡A«h¥H²Õ¦XªvÀø®ÄªG¸û²z·Q) 1. H2-²Õ´Ói¨üÅé«ú§Ü¾¯ 2. Bismuth 3. Omeprazole 4. Amoxicillin 5. Metronidazole
A.1, 2, 4
B.1, 3, 5
C.2, 3, 4
D.2, 4, 5
E.1, 4, 5
 


< ¤K¤Q¤»¦~¸ÕÃD¥Ø¿ý >